ESC 365 - One-year efficacy and safety of prasugrel and ticagrelor in patients with Acute Coronary Syndromes: results from a prospective and multicenter ACHILLES Registry.

ESC Premium Access

One-year efficacy and safety of prasugrel and ticagrelor in patients with Acute Coronary Syndromes: results from a prospective and multicenter ACHILLES Registry.

Session: Insights from acute coronary syndrome registries

Topic: Pharmacotherapy

Speaker: Doctor M. Esteve Pastor (Murcia, ES)

Event: ESC Congress 2019

Congress Presentation

Add to my library

About the speaker

Doctor Maria Asuncion Esteve Pastor

Virgen de la Arrixaca University Clinical Hospital, Murcia (Spain)

0 follower

5 more presentations in this session

Impact of potent P2Y12 inhibitors in adverse events reduction in diabetic patients with Acute Coronary Syndromes. An analysis from ACHILLES Registry.

Speaker: Doctor F. Marin (Murcia, ES)

Real world outcomes for clopidogrel versus ticagrelor treated patients with acute coronary syndrome: a systematic literature review and meta-analysis

Speaker: Professor D. Sibbing (Munich, DE)

Ischemic-bleeding balance according to history of prior bleeding in patients with acute coronary syndrome during treatment with dual antiplatelet therapy

Speaker: Ms B. Caneiro-Queija (Vigo, ES)

Percutaneous coronary intervention in the age of frailty

Speaker: Doctor M. Bergami (Bologna, IT)

Thrombus aspiration in combination with glycoprotein IIb/IIIa inhibitors with or without stent implantation in patients presenting with STEMI and high thrombus burden

Speaker: Mr K. Kintis (Athens, GR)

Access the full session

Insights from acute coronary syndrome registries

Speakers: Doctor M. Esteve Pastor, Doctor F. Marin, Professor D. Sibbing, Ms B. Caneiro-Queija, Doctor M. Bergami...

About the event

ESC Congress 2019

31 August - 4 September 2019

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources